At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 5, 2026 at 16:15 ET
Two Boston Scientific directors made open-market purchases totaling $277K in the week following the company's Q2 earnings report, which beat consensus but included a significant full-year guidance cut and a $700M-$800M restructuring plan. The insider buying is modest relative to the $69.2B market cap (0.0004%), but the timing, post-earnings and post-restructuring announcement, suggests directors see value at current levels despite the operational headwinds.
- Director Edward Ludwig purchased 5,000 shares at $45.48 for $227K on July 31.
- Director David Habiger purchased 1,042 shares at $48.07 for $50K on Aug 3.
- Total insider buying of $277K represents ~0.0004% of BSX's $69.2B market cap.
- Purchases occurred 2-5 days after Q2 earnings beat but guidance cut and restructuring announcement.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access